people are diagnosed with this disease around the world every year. In breast cancer, bone metastasis cause considerable pain and high patient morbidity. Calcium phosphate based cements (CPCs) are often ... this work is…
tumor initiation and progression. Growth factors not only mediate normal biological processes such as development and tissue repair but also tumorigenesis by contributing to proliferation and transformation in…
affected site have not shown better clinical outcome. Recently, two drug delivery forms were developed using human proteins as drug carrier for: (i) local sustained release from fibrin matrix ... from fibrin and…
study provided an overview of the state of CAR-T treatment for breast cancer, including its developments, difficulties, and potential solutions in both clinical and research settings. The effects ... offered a thorough…
nanoparticles was assessed against healthy (HEK-293, HUVEC, and MCF10A) and cancerous cell line (HeLa). The intensity of the reactive oxygen species was also measured to determine the induced oxidative ... biomedical…
leading cause of cancer related death in American women. For this reason development of a therapeutic breast cancer vaccine is an area of research that needs urgent attention offering these ... interest in cancer…
Western world {Jemal, 2005 #3160}. In patients diagnosed at an early stage of colorectal cancer, surgical excision followed by adjuvant radiation or chemotherapy leads to a high degree of response ... responses to…
reverse malignant transformation and inhibit latent tumor spread is an important goal in pancreatic cancer biology. Instead of targeting an upstream signaling module such as EGFR ... potent anti-K-RAS therapeutic target…
reverse malignant transformation and inhibit latent tumor spread is an important goal in pancreatic cancer biology. Instead of targeting an upstream signaling module such as EGFR ... potent anti-K-RAS therapeutic target…
Estimation of risk of distant recurrences in breast cancer patients based on biomarkers beyond current gold standard e.g. ER, PR, Her2, node status and Stage to influence treatment decision ... risk of recurrence. Thus…
Cervical cancer is the second most cause of cancer related death among women all over the world. Two HPV type-specific prophylactic vaccines are currently being used world-wide. However ... controversy over the side…
Background: Treatment for colorectal cancer (CRC) may result in physical, social, and psychological needs that affect patients’ quality of life post-treatment. A comprehensive assessment should be conducted to identify…
response to treatment is not durable, and transition to a castration-resistant prostate cancer (CRPC) state is inevitable and incurable. The CRPC cells overexpress functional AR, mutated AR, and most ... forms of AR…
tumor cell lines with optical reporters provides an excellent tool to study cancer genetics, tumor development and progression. The non-invasive target-specific molecular imaging allows us to study cancer ... treatment…
prior to cystectomy confers a small yet signifi cant survival benefi t in bladder cancer. Yet, it has not been widely adopted, since most patients do not benefi ... surgical management would be useful in selecting…
Bladder cancer is a heterogeneous disease and occupies highest incidence in developed country. Time-resolved fluoroimmunoassays (TRFIA) is a new detection technique with a feature of sensitive, simple and inexpensive
pressing need for the development of new devices facilitating advanced minimally invasive approaches for the in situ treatment of pancreatic cancer (PaCa). Additionally, studies now suggest that combinatorial approaches
Purpose: Breast cancer (BC) is the second leading cause of cancer deaths in women, and about 25% of BCs have overexpression of the HER2 receptor. Although HER2 targeted therapies have ... patientsâÂ?Â? outcome…
therapeutic targets in Prostate Cancer (PCa). Conventional antiandrogens lose effectiveness as cancer therapeutics because anti-androgen resistance usually develops after long term treatment. The challenge is that the…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.